By Cole Petrochko, Staff Writer, MedPage Today
Published: August 13, 2009
WASHINGTON -- The FDA has issued two final rules expanding access to investigational drugs for seriously ill patients who have no alternatives and regulating drug developers' charges for those medicines.
Thursday, August 13, 2009
Subscribe to:
Posts (Atom)
